This trial will test a new, shorter chemotherapy regimen for people with blood cancers before a transplant. Researchers want to know if the new regimen has the same or fewer side effects as the current one.
- Blood Cancers
1 Primary · 0 Secondary · Reporting Duration: in the first 30 days post-HCT
Awards & Highlights
2 Treatment Groups
patients hematologic malignancies other than multiple myeloma
1 of 2
patients with multiple myeloma
1 of 2
45 Total Participants · 2 Treatment Groups
Primary Treatment: Antithymocyte globulin (ATG) · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are currently enrolled in this research trial?
"Affirmative. According to clinicaltrials.gov, this research project is presently recruiting participants and was first posted on September 18th2019 with the most recent update taking place on October 3rd 2022. 45 patients are needed from one medical facility." - Anonymous Online Contributor
In what circumstances is Antithymocyte globulin (ATG) typically administered?
"Antithymocyte globulin (ATG) is often employed to treat severe hodgkin lymphoma. More broadly, it can be utilized as a palliative measure for conditions like [chronic lymphocytic leukemia](https://www.withpower.com/clinical-trials/chronic-lymphocytic-leukemia), allogeneic hematopoietic stem cell transplantation, chronic myelogenous leukemia and stem cell transplants." - Anonymous Online Contributor
What risks come with the use of Antithymocyte globulin (ATG)?
"Our team has attributed a score of 1 to the safety profile of antithymocyte globulin (ATG) due to its limited evidence in clinical trials." - Anonymous Online Contributor
Is it still possible to volunteer for this experiment?
"Affirmative. The clinicaltrials.gov database indicates that this medical trial, initially posted on September 18th 2019, is still looking for volunteers. Researchers are hoping to enroll 45 patients from a single location." - Anonymous Online Contributor